Cytosorbents (CTSO) Share-based Compensation (2010 - 2026)
Cytosorbents (CTSO) posted Share-based Compensation of $544000.0 for Q1 2026, down 38.6% on a QoQ basis from $886000.0 in Q4 2025, and down 33.5% year-over-year from $818000.0 in Q1 2025.
Cytosorbents (CTSO) Share-based Compensation (2010 - 2026) Analysis & Trends
Cytosorbents' Share-based Compensation history runs 17 years deep, the most recent figure standing at $544000.0 for Q1 2026.
- Quarterly Share-based Compensation fell 33.5% year-over-year to $544000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 22.08% YoY) and the FY2025 annual result came in at $2.8 million, down 26.46% from the prior year.
- Share-based Compensation was $544000.0 for Q1 2026 at Cytosorbents, down from $886000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.1 million in Q3 2025 and bottomed at $2024.0 in Q1 2024.
- A 5-year average of $879135.2 and a median of $886000.0 in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation tumbled 99.81% — and 2025, when it soared 40315.02%.
- Cytosorbents' Share-based Compensation stood at $870000.0 in 2022, then gained by 22.79% to $1.1 million in 2023, then declined by 13.88% to $920000.0 in 2024, then dropped by 3.7% to $886000.0 in 2025, then sank by 38.6% to $544000.0 in 2026.
- Business Quant data shows CTSO's Share-based Compensation at $544000.0 in Q1 2026, $886000.0 in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 544,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544,000.00 |
| Mar 31, 2026 | 544,000.00 |
| Dec 31, 2025 | 886,000.00 |
| Dec 31, 2025 | 886,000.00 |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 571,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 920,000.00 |
| Dec 31, 2024 | 920,000.00 |
| Sep 30, 2024 | 891,000.00 |
| Sep 30, 2024 | 891,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 2,024.00 |
| Mar 31, 2024 | 2,024.00 |
| Dec 31, 2023 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |